FSBI RCMG and Axbio Inc (USA) signed a cooperation agreement.
FSBI RCMG and Axbio Inc (USA) signed a cooperation agreement on June 28, 2019.
Anxun Biotechnology specializes in the development of molecular diagnostics and sequencing application in medicine.
Axbio Inc. has developed a new genetic sequencing technology that is significantly ahead of the available analogues. It presented its first product, the AXP100 sequencer. The device is a highly sensitive detector of biomolecules, which allows implementing the most advanced technology of nanopore sequencing by DNA synthesis and single-nucleotide detection.
Working together with Axbio Inc. will provide an opportunity for Russian medical and research centers, and laboratories to use the innovative tools for genetic analysis.